View in EDS

Optimizing Antibody-Based Therapies for Alzheimer's Disease: From Clinical Limitations to Molecular Engineering Innovations.

Saved in:
Bibliographic Details
Title: Optimizing Antibody-Based Therapies for Alzheimer's Disease: From Clinical Limitations to Molecular Engineering Innovations.
Authors: Liu Q; Department of Neurology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhejiang 310009, China., Lin RR; Department of Neurology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhejiang 310009, China.
Source: Aging and disease [Aging Dis] 2026 Jun 04. Date of Electronic Publication: 2026 Jun 04.
Publication Type: Journal Article; Review
Journal Info: Publisher: JKL International Country of Publication: United States NLM ID: 101540533 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-5250 (Electronic) Linking ISSN: 21525250 NLM ISO Abbreviation: Aging Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42295086
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Optimizing Antibody-Based Therapies for Alzheimer's Disease: From Clinical Limitations to Molecular Engineering Innovations.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Liu+Q%22">Liu Q</searchLink>; Department of Neurology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhejiang 310009, China.<br /><searchLink fieldCode="AU" term="%22Lin+RR%22">Lin RR</searchLink>; Department of Neurology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhejiang 310009, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101540533%22">Aging and disease</searchLink> [Aging Dis] 2026 Jun 04. <i>Date of Electronic Publication: </i>2026 Jun 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22JKL+International%22">JKL International </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101540533 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2152-5250 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221525250%22">21525250 </searchLink><i>NLM ISO Abbreviation: </i>Aging Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42295086
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.14336/AD.2026.0292
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Optimizing Antibody-Based Therapies for Alzheimer's Disease: From Clinical Limitations to Molecular Engineering Innovations.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Liu Q
      – PersonEntity:
          Name:
            NameFull: Lin RR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 06
              Text: 2026 Jun 04
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2152-5250
          Titles:
            – TitleFull: Aging and disease
              Type: main
ResultId 1